Iptacopan significantly slowed kidney function decline over 24 months compared with placebo in adults with IgA nephropathy. The complement inhibitor was granted accelerated approved in 2024; continued ...
Results support initiation of Phase 2b clinical trial of tonlamarsen in patients with acute severe hypertension SOUTH SAN FRANCISCO, Calif., & PRINCETON, N.J.-- (BUSINESS WIRE)--March 28, 2026-- ...
Monthly injections of tonlamarsen lowered AGT but didn’t reduce BP in patients already on multiple antihypertensive drugs.
For patients with uncontrolled hypertension already on two or more medications, monthly injections of tonlamarsen (Kardigan) more effectively lowered plasma angiotensinogen (AGT) levels than a single ...
The Artemis II countdown will begin March 30, setting up a launch attempt on April 1 at 6:24 p.m. Eastern Time.
The crew of the Artemis II mission will include the first woman and person of color to travel to deep space, ushering in a new era of representation in exploration beyond Earth.
Adults with insulin-deficient type 2 diabetes had a decrease in HbA1c that was maintained for 1 year after receiving a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results